H56N (p.His56Asn) variant of GAA (Lysosomal alpha-glucosidase)
H56N (p.His56Asn) in GAA (Lysosomal alpha-glucosidase) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Glycogen storage disease, type II. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data, published literature, and structural context.
H56N (p.His56Asn) variant details
- p.His56Asn
- rs781650771
- ClinGen CA294886642
- ClinVar RCV002685537
- ExAC rs781650771
- Uncertain significance
- Glycogen storage disease, type II
- Missense
- Variant Prioritization Score for Impact Estimate 0.237
- REVEL 0.13
- MetaLR 0.39
- MetaSVM -0.62
- CADD 0.12
- PolyPhen-2 0.01
- SIFT 0.63
- ClinVar: Uncertain significance (Glycogen storage disease, type II)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Most common in the Non-Finnish European population (allele frequency 1.5e-05)
- Structural context available
- Cited in: Pompe Disease. (PMID 20301438)
- Cited in: 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and… (PMID 25173338)